M D Anderson Cancer Center CCOP Research Base

Houston, Texas 77030

0 studies enrolling now · 2 studies all time

What they study most

Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Lymphoma, Neurotoxicity, Ovarian Clear Cell Cystadenocarcinoma, Radiation Toxicity, Stage III Ovarian Cancer, Stage IV Ovarian Cancer

Studies at this site

• Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma — Completed
• Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer — Completed